|
|
||||||||
Rigel Pharmaceuticals, Inc., South San Francisco, CA 94080
TRAC-1 (T cell RING (really interesting new gene) protein identified in activation screen) is a novel E3 ubiquitin ligase identified from a retroviral vector-based T cell surface activation marker screen. The C-terminal truncated TRAC-1 specifically inhibited anti-TCR-mediated CD69 up-regulation in Jurkat cells, a human T leukemic cell line. In this study, we show that TRAC-1 is a RING finger ubiquitin E3 ligase with highest expression in lymphoid tissues. Point mutations that disrupt the Zn2+-chelating ability of its amino-terminal RING finger domain abolished TRAC-1s ligase activity and the dominant inhibitory effect of C-terminal truncated TRAC-1 on TCR stimulation. The results of in vitro biochemical studies indicate that TRAC-1 can stimulate the formation of both K48- and K63-linked polyubiquitin chains and therefore could potentially activate both degradative and regulatory ubiquitin-dependent pathways. Antisense oligonucleotides to TRAC-1 specifically reduced TRAC-1 mRNA levels in Jurkat and primary T cells and inhibited their activation in response to TCR cross-linking. Collectively, these results indicate that the E3 ubiquitin ligase TRAC-1 functions as a positive regulator of T cell activation.
This article has been cited by other articles:
![]() |
K.-i. Arimoto, H. Takahashi, T. Hishiki, H. Konishi, T. Fujita, and K. Shimotohno Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125 PNAS, May 1, 2007; 104(18): 7500 - 7505. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Fortier and J. Kornbluth NK Lytic-Associated Molecule, Involved in NK Cytotoxic Function, Is an E3 Ligase. J. Immunol., June 1, 2006; 176(11): 6454 - 6463. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Wohlfert, L. Gorelik, R. Mittler, R. A. Flavell, and R. B. Clark Cutting Edge: Deficiency in the E3 Ubiquitin Ligase Cbl-b Results in a Multifunctional Defect in T Cell TGF-beta Sensitivity In Vitro and In Vivo J. Immunol., February 1, 2006; 176(3): 1316 - 1320. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |